Real-world outcomes of second-line ramucirumab plus paclitaxel in patients with advanced gastric or gastroesophageal junction adenocarcinoma: A nationwide retrospective study in Korea (KCSG-ST19-16).
Real-world outcomes of second-line ramucirumab plus paclitaxel in patients with advanced gastric or gastroesophageal junction adenocarcinoma: A nationwide retrospective study in Korea (KCSG-ST19-16).
저자
Zang, Dae Young; Han, Hye Sook; Kim, Bum Jun; Jee, Hee-Jung; Suh, Young Ju; An, Hyonggin; Byun, Ji-Hye; Kim, Dong Sook; Park, Se Hoon; Rha, Sun Young; Oh, Do-Youn; Kim, Jong Gwang; Bae, Woo Kyun; Kim, In-Ho; Sym, Sun Jin; Oh, So Yeon; Kim, Hyeong Su; Lee, Keun Wook; Ryu, Min-Hee